Daunorubicin hydrochloride and cytarabine liposome

A form of the anticancer drugs daunorubicin hydrochloride and cytarabine that is contained inside very tiny, fat-like particles and is used to treat adults with certain types of newly diagnosed acute myeloid leukemia. Daunorubicin hydrochloride and cytarabine liposome may have fewer side effects and work better than other forms of these drugs. It is also being studied in the treatment of other types of cancer. Daunorubicin hydrochloride and cytarabine liposome is a type of anthracycline antibiotic, a type of topoisomerase inhibitor, and a type of antimetabolite. Also called Vyxeos.